Rockwell Medical, Inc.
RMTI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001041024
No open-market purchases or sales by Rockwell Medical, Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Rockwell Medical, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +2 vs. Q3 2023
- Shares held
- 5.12M
- −70.3K (−1.4%) vs. Q3 2023
- Total value
- $9.68M
- −$1.12M (−10.4%) vs. Q3 2023
- New holders
- 8
- 12 more added
- Sold out
- 6
- 9 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RMTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 37 | $1.90M |
| Q1 2026 | 42 | $3.55M |
| Q4 2025 | 36 | $2.91M |
| Q3 2025 | 36 | $4.03M |
| Q2 2025 | 42 | $5.00M |
| Q1 2025 | 46 | $7.87M |
| Q4 2024 | 53 | $16.8M |
| Q3 2024 | 53 | $37.5M |
| Q2 2024 | 31 | $11.0M |
| Q1 2024 | 33 | $9.04M |
| Q4 2023 | 34 | $9.68M |
| Q3 2023 | 32 | $10.8M |
| Q2 2023 | 40 | $16.8M |
| Q1 2023 | 33 | $3.56M |
| Q4 2022 | 32 | $2.91M |
| Q3 2022 | 36 | $3.32M |
| Q2 2022 | 36 | $2.45M |
| Q1 2022 | 59 | $9.06M |
| Q4 2021 | 62 | $7.65M |
| Q3 2021 | 62 | $7.04M |
| Q2 2021 | 78 | $15.0M |
| Q1 2021 | 92 | $25.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Rockwell Medical, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ogorek Anthony Joseph | 226 | $0 | 0.00% | +226 | New |
| Royal Bank of Canada | 115 | $0 | 0.00% | +115 | New |
| JPMorgan Chase & Co | 35 | $66 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 90 | $170 | 0.00% | −3,760−97.7% | Reduced |
| Comerica Bank | 163 | $308 | 0.00% | 00.0% | Unchanged |
| Rise Advisors, LLC | 215 | $406 | 0.00% | 00.0% | Unchanged |
| Scarborough Advisors, LLC | 269 | $508 | 0.00% | +269 | New |
| Wells Fargo & Company | 809 | $1.53K | 0.00% | +11+1.4% | Added |
| Bank of America Corp | 1,990 | $3.76K | 0.00% | +92+4.8% | Added |
| Tower Research Capital LLC (TRC) | 2,687 | $5.08K | 0.00% | +2,687 | New |
| Advisor Group Holdings, Inc. | 3,211 | $6.07K | 0.00% | −4,400−57.8% | Reduced |
| Traphagen Investment Advisors LLC | 11,100 | $21.0K | 0.00% | +11,100 | New |
| Cetera Advisor Networks LLC | 14,127 | $26.7K | 0.00% | 00.0% | Unchanged |
| SkyOak Wealth, LLC | 17,045 | $32.2K | 0.01% | −2,500−12.8% | Reduced |
| Great Valley Advisor Group, Inc. | 17,961 | $33.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 23,841 | $45.1K | 0.00% | +23,841 | New |
| Squarepoint Ops LLC | 24,522 | $46.3K | 0.00% | +24,522 | New |
| Morgan Stanley | 26,463 | $50.0K | 0.00% | −7,496−22.1% | Reduced |
| WealthTrust Axiom LLC | 31,500 | $59.5K | 0.02% | +10,400+49.3% | Added |
| Jane Street Group, LLC | 32,279 | $61.0K | 0.00% | +6,156+23.6% | Added |
| HighTower Advisors, LLC | 32,698 | $62.0K | 0.00% | −22−0.1% | Reduced |
| Two Sigma Investments, LP | 47,733 | $90.2K | 0.00% | +47,733 | New |
| Susquehanna International Group, LLP | 49,632 | $93.8K | 0.00% | −100,349−66.9% | Reduced |
| Northern Trust Corp | 63,838 | $120.7K | 0.00% | +106+0.2% | Added |
| State Street Corp | 74,304 | $140.4K | 0.00% | +40,700+121.1% | Added |
| Renaissance Technologies LLC | 98,200 | $186.0K | 0.00% | +84,157+599.3% | Added |
| Marshall Wace, LLP | 175,096 | $330.9K | 0.00% | −66,805−27.6% | Reduced |
| BlackRock Inc. | 178,201 | $336.8K | 0.00% | −354−0.2% | Reduced |
| Raymond James & Associates | 220,979 | $417.6K | 0.00% | +30,309+15.9% | Added |
| Geode Capital Management, LLC | 283,923 | $536.7K | 0.00% | +40,915+16.8% | Added |
| Perkins Capital Management Inc | 349,934 | $661.0K | 0.56% | +274,891+366.3% | Added |
| Richmond Brothers, Inc. | 412,433 | $779.5K | 1.36% | +2,081+0.5% | Added |
| Vanguard Group Inc | 1,074,975 | $2.03M | 0.00% | +698,160+185.3% | Added |
| Armistice Capital, LLC | 1,852,000 | $3.50M | 0.09% | −965,000−34.3% | Reduced |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −134,200−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −60,286−100.0% | Sold out |
| Sigma Investment Counselors Inc | 0 | $0 | 0.00% | −12,927−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Stonebridge Capital Advisors LLC | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −65−100.0% | Sold out |